Vistra Balance Sheet Health

Financial Health criteria checks 3/6

Vistra has a total shareholder equity of $8.7B and total debt of $15.5B, which brings its debt-to-equity ratio to 179.3%. Its total assets and total liabilities are $37.9B and $29.2B respectively. Vistra's EBIT is $3.6B making its interest coverage ratio 4. It has cash and short-term investments of $930.0M.

Key information

179.3%

Debt to equity ratio

US$15.52b

Debt

Interest coverage ratio4x
CashUS$930.00m
EquityUS$8.65b
Total liabilitiesUS$29.23b
Total assetsUS$37.88b

Recent financial health updates

No updates

Recent updates

Vistra: Too Much Hype Priced In

Nov 22

Vistra Corp. (NYSE:VST) Looks Just Right With A 33% Price Jump

Nov 22
Vistra Corp. (NYSE:VST) Looks Just Right With A 33% Price Jump

What Is Vistra Corp.'s (NYSE:VST) Share Price Doing?

Nov 15
What Is Vistra Corp.'s (NYSE:VST) Share Price Doing?

Vistra: The Nuclear Hype Is Getting Out Of Hand (Rating Downgrade)

Oct 23

Nuclear News - Vistra, Constellation Energy, Denison Mines

Oct 09

Broken Equilibrium: How Vistra Is Growing Like A Startup

Oct 01

Are Investors Undervaluing Vistra Corp. (NYSE:VST) By 42%?

Oct 01
Are Investors Undervaluing Vistra Corp. (NYSE:VST) By 42%?

Vistra Energy Goes Nuclear

Sep 23

Cheap Vistra Stock Is Poised To Exploit Multiple, Strong Trends

Sep 17

What You Can Learn From Vistra Corp.'s (NYSE:VST) P/E

Sep 10
What You Can Learn From Vistra Corp.'s (NYSE:VST) P/E

Vistra Corp.: Essential Holding For Your Growth Portfolio

Aug 14

Vistra Corp: Mismatch Of Demand, Supply Promises Bright Future

Jul 14

What Is Vistra Corp.'s (NYSE:VST) Share Price Doing?

Jul 13
What Is Vistra Corp.'s (NYSE:VST) Share Price Doing?

Vistra: This Sector Outperformer Looks Undervalued At This Price

Jun 13

Vistra Corp. (NYSE:VST) Looks Just Right With A 45% Price Jump

May 25
Vistra Corp. (NYSE:VST) Looks Just Right With A 45% Price Jump

Here's What To Make Of Vistra's (NYSE:VST) Decelerating Rates Of Return

May 21
Here's What To Make Of Vistra's (NYSE:VST) Decelerating Rates Of Return

Third Point - Vistra: In A Pole Position To Capitalize On Trends

May 02

Vistra Adds Vital Nuclear Power Capacity

Apr 22

Vistra Corp. (NYSE:VST) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected

Apr 04
Vistra Corp. (NYSE:VST) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected

An Intrinsic Calculation For Vistra Corp. (NYSE:VST) Suggests It's 38% Undervalued

Mar 22
An Intrinsic Calculation For Vistra Corp. (NYSE:VST) Suggests It's 38% Undervalued

Earnings Beat: Vistra Corp. (NYSE:VST) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Mar 04
Earnings Beat: Vistra Corp. (NYSE:VST) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Vistra: Shares Go Parabolic, Take Caution Into Earnings

Feb 25

Little Excitement Around Vistra Corp.'s (NYSE:VST) Revenues

Feb 07
Little Excitement Around Vistra Corp.'s (NYSE:VST) Revenues

Is It Time To Consider Buying Vistra Corp. (NYSE:VST)?

Jan 17
Is It Time To Consider Buying Vistra Corp. (NYSE:VST)?

Returns On Capital Are Showing Encouraging Signs At Vistra (NYSE:VST)

Dec 27
Returns On Capital Are Showing Encouraging Signs At Vistra (NYSE:VST)

Vistra Corp.: A Green Transformation With Significant Upside Potential

Dec 17

Vistra: We Believe In The Potential For Strong CAGR The Next 5 Years

Oct 19

Vistra: Regulatory Nightmares Compounded By A Weak Balance Sheet (Rating Downgrade)

Oct 04

Financial Position Analysis

Short Term Liabilities: VST's short term assets ($8.5B) exceed its short term liabilities ($7.7B).

Long Term Liabilities: VST's short term assets ($8.5B) do not cover its long term liabilities ($21.6B).


Debt to Equity History and Analysis

Debt Level: VST's net debt to equity ratio (168.6%) is considered high.

Reducing Debt: VST's debt to equity ratio has increased from 148.4% to 179.3% over the past 5 years.

Debt Coverage: VST's debt is well covered by operating cash flow (26.4%).

Interest Coverage: VST's interest payments on its debt are well covered by EBIT (4x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:38
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vistra Corp. is covered by 25 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James ThalackerBMO Capital Markets Equity Research
null nullBMO Capital Markets Equity Research
Moses SuttonBNP Paribas Exane